Study: Sickle Cell Drug Reduces Death Risk A drug commonly prescribed for patients with sickle cell anemia not only eases symptoms of the disease, but also reduces the risk of death by 40 percent, a new study published in the Journal of the American Medical Association says. But it is unclear if hydroxyurea is appropriate for children. Hear NPR's Vicky Que.
NPR logo

Study: Sickle Cell Drug Reduces Death Risk

  • Download
  • <iframe src="https://www.npr.org/player/embed/1216809/1216810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Study: Sickle Cell Drug Reduces Death Risk

Study: Sickle Cell Drug Reduces Death Risk

Study: Sickle Cell Drug Reduces Death Risk

  • Download
  • <iframe src="https://www.npr.org/player/embed/1216809/1216810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A drug commonly prescribed for patients with sickle cell anemia not only eases symptoms of the disease, but also reduces the risk of death by 40 percent, a new study published in the Journal of the American Medical Association says. But it is unclear if hydroxyurea is appropriate for children. Hear NPR's Vicky Que.